Standout Papers

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma faili... 2017 2026 2020 2023 346
  1. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase (2017)
    Yok‐Lam Kwong, Thomas S. Y. Chan et al. Blood

Citation Impact

2 by Nobel laureates 55 standout
Sub-graph 1 of 25

Citing Papers

Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment
2024 Standout
2 intermediate papers

Works of Limei Poon being referenced

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
2017 Standout

Author Peers

Author PFM Oncology Genetics Immunology Last Decade Papers Cites
Limei Poon 321 345 65 251 22 523
X Li 8 36 3 38 6 370
Jiří Hodan 5 4 6 2 65 1.1k
Sharyn Leis 7 6 11 15 598
Peter J. Adamson 117 179 23 50 14 550
ThaoNguyen Nguyen 21 2 7 389

All Works

Loading papers...

Rankless by CCL
2026